StockNote
PMC
Pharmedic Pharmaceutical Materials Joint Stock Company (PMC), formerly known as Pharimex Medical Direct Import-Export Company, was established in 1981. In 1997, the Company transformed its business model in the form of a Joint Stock Company. The company specializes in manufacturing and trading pharmaceuticals, medicinal materials, cosmetics, medical supplies and other products in the medical industry. The product is distributed throughout Vietnam but the main consumption market is Ho Chi Minh City. The company accounts for about 2% of the domestic market share of manufactured drugs, most of which are conventional drugs. On October 9, 2009, PMC officially traded on the Hanoi Stock Exchange (HNX).
PMC currently has a market capitalization of roughly VND 1.194 billion, placing it in the mid-cap group on the Vietnamese stock market. Its current P/E of 16,2x is 47% above its own 8-year average (11x), suggesting the stock is trading richer than its historical norm. P/B stands at 4,7x, 59% above its multi-year average of 3x. Return on equity (ROE) is at 29,6%, down from 32,2% the year before. Its debt-to-equity ratio of 0,3x is low, reflecting a conservative capital structure. In 2025, revenue grew 10% year-on-year while after-tax profit grew 3%.
This note is generated automatically from the stock's real financial data, for reference only — not investment advice.
Revenue & Profit
Unit: VND billion. Growth (%) vs. previous period.
Market Cap
Unit: VND billion. Year-end values; current year uses latest session.
Debt / Equity
Unit: x. Financial debt over shareholders' equity.
Data aggregated from cafef.vn and VNDirect, for reference only, not investment advice.